330 related articles for article (PubMed ID: 12683241)
1. HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons.
Kofman A; Graf M; Bojak A; Deml L; Bieler K; Kharazova A; Wolf H; Wagner R
Tsitologiia; 2003; 45(1):86-93. PubMed ID: 12683241
[TBL] [Abstract][Full Text] [Related]
2. Codon usage-mediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation.
Kofman A; Graf M; Deml L; Wolf H; Wagner R
Tsitologiia; 2003; 45(1):94-100. PubMed ID: 12683242
[TBL] [Abstract][Full Text] [Related]
3. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
[TBL] [Abstract][Full Text] [Related]
4. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.
Deml L; Bojak A; Steck S; Graf M; Wild J; Schirmbeck R; Wolf H; Wagner R
J Virol; 2001 Nov; 75(22):10991-1001. PubMed ID: 11602739
[TBL] [Abstract][Full Text] [Related]
5. Co-influence of transgene expression in mammalian cells. Mutual influence of transgenes on their expression in mammalian cells.
Kofman A; Graf M; Deml L; Kharazova A; Wolf H; Wagner R
Tsitologiia; 2003; 45(4):387-91. PubMed ID: 14520870
[TBL] [Abstract][Full Text] [Related]
6. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
[TBL] [Abstract][Full Text] [Related]
7. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
Lee AH; Lee HY; Sung YC
Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
[TBL] [Abstract][Full Text] [Related]
8. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
9. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.
Kotsopoulou E; Kim VN; Kingsman AJ; Kingsman SM; Mitrophanous KA
J Virol; 2000 May; 74(10):4839-52. PubMed ID: 10775623
[TBL] [Abstract][Full Text] [Related]
10. Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.
Wang S; Farfan-Arribas DJ; Shen S; Chou TH; Hirsch A; He F; Lu S
Vaccine; 2006 May; 24(21):4531-40. PubMed ID: 16140431
[TBL] [Abstract][Full Text] [Related]
11. Effects of mutations in an HIV-1 gag gene containing a 107-codon tandem repeat in the matrix region on assembly and processing of the protein product.
Liao WH; Chiu HC; Wang CT
J Med Virol; 2004 Dec; 74(4):528-35. PubMed ID: 15484268
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.
Schneider R; Campbell M; Nasioulas G; Felber BK; Pavlakis GN
J Virol; 1997 Jul; 71(7):4892-903. PubMed ID: 9188551
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein.
Chan WE; Chen SS
Virology; 2006 May; 348(2):418-29. PubMed ID: 16472834
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
15. Sequence requirements for incorporation of human immunodeficiency virus gag-beta-galactosidase fusion proteins into virus-like particles.
Wang CT; Lai HY; Yang CC
J Med Virol; 1999 Oct; 59(2):180-8. PubMed ID: 10459153
[TBL] [Abstract][Full Text] [Related]
16. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production.
Koldej R; Cmielewski P; Stocker A; Parsons DW; Anson DS
J Gene Med; 2005 Nov; 7(11):1390-9. PubMed ID: 16025547
[TBL] [Abstract][Full Text] [Related]
17. High variability of the gag/pol transframe region among HIV-1 isolates.
Candotti D; Chappey C; Rosenheim M; M'Pelé P; Huraux JM; Agut H
C R Acad Sci III; 1994 Feb; 317(2):183-9. PubMed ID: 7994608
[TBL] [Abstract][Full Text] [Related]
18. E. coli ribosomes re-phase on retroviral frameshift signals at rates ranging from 2 to 50 percent.
Weiss RB; Dunn DM; Shuh M; Atkins JF; Gesteland RF
New Biol; 1989 Nov; 1(2):159-69. PubMed ID: 2562219
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
Liao WH; Wang CT
Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
[TBL] [Abstract][Full Text] [Related]
20. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
